Open Innovation in Drug Discovery
The Wiley Online Library site posted an article from the journal Molecular Informatics which discusses some of the strengths and limitations of open innovation in drug discovery. The ever-growing availability of large-scale open data and its maturation is having a significant impact on industrial drug-discovery, as well as on academic and non-profit research. As industry is changing to an ‘open innovation’ business concept, precompetitive initiatives and strong public-private partnerships including academic research cooperation partners are gaining more and more importance.
Click here to read the full article.